Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
217 Evaluating biomarkers of JTX-8064 (anti-LILRB2/ILT4 monoclonal antibody) in an ex vivo human tumor histoculture system to inform clinical development
Compose a Response to This Article
Other responses
No responses have been published for this article.
